Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

HUMAN DISEASE

Priority index for human genetics and drug discovery

Nature Genetics volume 51, pages 1073–1075 (2019)Cite this article

Subjects

Although human genetics can help identify new drug targets, the best way to prioritize genes as therapeutic targets is uncertain. A new study describes a framework to prioritize potential targets by integrating genome-wide association data with genomic features, disease ontologies and network connectivity.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Approaches to prioritize therapeutic targets on the basis of human genetic studies.

References

  1. Plenge, R. M., Scolnick, E. M. & Altshuler, D. Nat. Rev. Drug Discov. 12, 581–594 (2013).

    Article  CAS  Google Scholar 

  2. Nelson, M. R. et al. Nat. Genet. 47, 856–860 (2015).

    Article  CAS  Google Scholar 

  3. Fang, H. et al. Nat. Genet. https://doi.org/10.1038/s41588-019-0456-1 (2019).

  4. Rossin, E. J. et al. PLoS Genet. 7, e1001273 (2011).

    Article  CAS  Google Scholar 

  5. de Lange, K. M. et al. Nat. Genet. 49, 256–261 (2017).

    Article  Google Scholar 

  6. Sun, B. B. et al. Nature 558, 73–79 (2018).

    Article  CAS  Google Scholar 

  7. Raychaudhuri, S. et al. Nat. Genet. 41, 1313–1318 (2009).

    Article  CAS  Google Scholar 

  8. Okada, Y. et al. Nature 506, 376–381 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research & Early Development, Celgene Corporation, Cambridge, MA, USA

    Robert M. Plenge

Authors
  1. Robert M. Plenge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert M. Plenge.

Ethics declarations

Competing Interests

R.M.P. is a full-time employee at Celgene.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Plenge, R.M. Priority index for human genetics and drug discovery. Nat Genet 51, 1073–1075 (2019). https://doi.org/10.1038/s41588-019-0460-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-019-0460-5

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research